These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36336684)

  • 1. Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional study.
    Seeberg KA; Hofsø D; Borgeraas H; Grimnes JO; Fatima F; Seeberg LT; Kvan NP; Svanevik M; Hertel JK; Hjelmesæth J
    BMC Gastroenterol; 2022 Nov; 22(1):448. PubMed ID: 36336684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis : A Randomized Controlled Trial.
    Seeberg KA; Borgeraas H; Hofsø D; Småstuen MC; Kvan NP; Grimnes JO; Lindberg M; Fatima F; Seeberg LT; Sandbu R; Hjelmesæth J; Hertel JK
    Ann Intern Med; 2022 Jan; 175(1):74-83. PubMed ID: 34843380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity.
    Coccia F; Testa M; Guarisco G; Bonci E; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
    Endocrine; 2020 Mar; 67(3):569-578. PubMed ID: 31858390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
    Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
    Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening.
    Poustchi H; Alaei-Shahmiri F; Aghili R; Nobarani S; Malek M; Khamseh ME
    Arch Iran Med; 2021 Mar; 24(3):177-186. PubMed ID: 33878875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
    Coccia F; Testa M; Guarisco G; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):106-113. PubMed ID: 31677889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between abdominal fat stores and liver fat, pancreatic fat, and metabolic comorbidities in a pediatric population with non-alcoholic fatty liver disease.
    Trout AT; Hunte DE; Mouzaki M; Xanthakos SA; Su W; Zhang B; Dillman JR
    Abdom Radiol (NY); 2019 Sep; 44(9):3107-3114. PubMed ID: 31312893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
    PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features.
    Cazzo E; Jimenez LS; Gestic MA; Utrini MP; Chaim FHM; Chaim FDM; Pareja JC; Chaim EA
    Obes Surg; 2018 Jan; 28(1):187-194. PubMed ID: 28741239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study.
    Toman D; Vavra P; Jelinek P; Ostruszka P; Ihnat P; Foltys A; Pelikan A; Roman J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):195-203. PubMed ID: 33885048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cardiovascular factors in diabetic patients with non-alcoholic fatty liver disease.
    Cholongitas E; Tsilingiris D; Diamantopoulou P; Mastrogianni E; Tentolouris A; Karagiannakis D; Moyssakis I; Papatheodoridis GV; Tentolouris N
    Hormones (Athens); 2022 Mar; 21(1):133-145. PubMed ID: 34716911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT).
    Lavynenko O; Abdul-Ghani M; Alatrach M; Puckett C; Adams J; Abdelgani S; Alkhouri N; Triplitt C; Clarke GD; Vasquez JA; Li J; Cersosimo E; Gastaldelli A; DeFronzo RA
    Diabetes Obes Metab; 2022 May; 24(5):899-907. PubMed ID: 35014145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus.
    Gupta A; Anoop S; Ansari IA; Prakash S; Misra A
    Clin Nutr ESPEN; 2021 Dec; 46():519-526. PubMed ID: 34857244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency.
    Luger M; Kruschitz R; Kienbacher C; Traussnigg S; Langer FB; Schindler K; Würger T; Wrba F; Trauner M; Prager G; Ludvik B
    Obes Surg; 2016 Oct; 26(10):2425-32. PubMed ID: 26989059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Histopathological and Biochemical Aspects of NAFLD With the Severity of Liver Fibrosis in Individuals With Obesity: Cross-sectional Study.
    Carneiro CRG; Ayres ABS; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2024 May; 34(5):1569-1574. PubMed ID: 38502518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of ectopic fat storage in the liver and pancreas using six-point Dixon MRI and its association with insulin sensitivity and β-cell function in patients with central obesity.
    Cao MJ; Wu WJ; Chen JW; Fang XM; Ren Y; Zhu XW; Cheng HY; Tang QF
    Eur Radiol; 2023 Dec; 33(12):9213-9222. PubMed ID: 37410109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional study.
    Cazzo E; Jimenez LS; Gallo Fde F; Pareja JC; Chaim EA
    Sao Paulo Med J; 2016; 134(1):79-83. PubMed ID: 26786607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes.
    Denimal D; Béland-Bonenfant S; Pais-de-Barros JP; Rouland A; Bouillet B; Duvillard L; Vergès B; Petit JM
    Cardiovasc Diabetol; 2023 Nov; 22(1):310. PubMed ID: 37940926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.